Follow
G Y Zou
G Y Zou
Western University
Verified email at robartsinc.com - Homepage
Title
Cited by
Cited by
Year
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration
JP Vandenbroucke, E Elm, DG Altman, PC Gøtzsche, CD Mulrow, ...
Annals of internal medicine 147 (8), W-163-W-194, 2007
96822007
A modified poisson regression approach to prospective studies with binary data
G Zou
American journal of epidemiology 159 (7), 702-706, 2004
85482004
STrengthening the REporting of Genetic Association Studies (STREGA)—an extension of the STROBE statement
J Little, JPT Higgins, JPA Ioannidis, D Moher, F Gagnon, E Von Elm, ...
Genetic Epidemiology: The Official Publication of the International Genetic …, 2009
14522009
Toward using confidence intervals to compare correlations.
GY Zou
Psychological methods 12 (4), 399, 2007
7572007
C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and …
MH Mosli, G Zou, SK Garg, SG Feagan, JK MacDonald, N Chande, ...
Official journal of the American College of Gastroenterology| ACG 110 (6 …, 2015
6852015
Extension of the modified Poisson regression model to prospective studies with correlated binary data
GY Zou, A Donner
Statistical methods in medical research 22 (6), 661-670, 2013
6512013
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
R Khanna, B Bressler, BG Levesque, G Zou, LW Stitt, GR Greenberg, ...
The Lancet 386 (10006), 1825-1834, 2015
4842015
Sample size formulas for estimating intraclass correlation coefficients with precision and assurance
GY Zou
Statistics in medicine 31 (29), 3972-3981, 2012
4332012
A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial
RD Feldman, GY Zou, MK Vandervoort, CJ Wong, SAE Nelson, ...
hypertension 53 (4), 646-653, 2009
4122009
Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease
BG Feagan, JWD McDonald, R Panaccione, RA Enns, CN Bernstein, ...
Gastroenterology 146 (3), 681-688. e1, 2014
3822014
Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials
BG Feagan, WJ Sandborn, U Mittmann, S Bar-Meir, G D’Haens, ...
Jama 299 (14), 1690-1697, 2008
3522008
Development and validation of a histological index for UC
MH Mosli, BG Feagan, G Zou, WJ Sandborn, G D'Haens, R Khanna, ...
Gut 66 (1), 50-58, 2017
3372017
The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
NV Casteele, R Khanna, BG Levesque, L Stitt, GY Zou, S Singh, ...
Gut 64 (10), 1539-1545, 2015
3272015
On the estimation of additive interaction by use of the four-by-two table and beyond
GY Zou
American journal of epidemiology 168 (2), 212-224, 2008
2842008
Construction of confidence limits about effect measures: a general approach
GY Zou, A Donner
Statistics in medicine 27 (10), 1693-1702, 2008
2642008
Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis
NM Vashist, M Samaan, MH Mosli, CE Parker, JK MacDonald, SA Nelson, ...
Cochrane Database of Systematic Reviews, 2018
2472018
The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis
BG Feagan, WJ Sandborn, G D'Haens, S Pola, JWD McDonald, ...
Gastroenterology 145 (1), 149-157. e2, 2013
2152013
Confidence interval estimation for the Bland–Altman limits of agreement with multiple observations per individual
GY Zou
Statistical methods in medical research 22 (6), 630-642, 2013
2112013
Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care
MK DeGorter, RG Tirona, UI Schwarz, YH Choi, GK Dresser, N Suskin, ...
Circulation: Cardiovascular Genetics 6 (4), 400-408, 2013
2102013
A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity
R Khanna, G Zou, G D'haens, BG Feagan, WJ Sandborn, MK Vandervoort, ...
Alimentary pharmacology & therapeutics 41 (1), 77-86, 2015
2032015
The system can't perform the operation now. Try again later.
Articles 1–20